| Application no. and date | 17851619.1 (espacenet) (Federated) (European Patent Register), 20170915 | | Patent/reg. no. and date | DK/EP 3512517, 20250319 | | Publication date | 20190724 | | Priority no. and date | US 201662395259 P, 20160915, US 201762532728 P, 20170714 | | EP pub. no. and date |
EP 3512517 20190724 | | Effective date | | | Applicant/owner | Prilenia Neurotherapeutics Ltd., Yakum Greenwork Business Park
Mindspace Offices
Building D
6097200 Yakum, IL | | Applicant ref. no. | V2505-018-DK | | Inventor | HAYDEN, Michael, c/o 5 Basel Street
P.O. Box 3190
49131 Patach-Tikva, IL,
POULADI, Mahmoud, Abdulhossein, 105 Clementi Road
Block B 04-02
Singapore 129789, SG | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/451 (2006.01) , A61P 25/00 (2006.01) , A61P 25/14 (2006.01) , A61P 25/22 (2006.01) , A61P 25/24 (2006.01) | | Title | ANVENDELSE AF PRIDOPIDIN TIL BEHANDLING AF ANGST OG DEPRESSION | | Int. application no. | US2017051814 | | Int. publication no. | WO2018053287 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
